ACE inhibitors/spironolactone: risk of hyperkalaemia

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2001年 / 857卷 / 1期

关键词：

Renal Impairment; Furosemide; Ventricular Arrhythmia; Hydrochlorothiazide; Spironolactone;

D O I：

10.2165/00128415-200108570-00008

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[1] Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone
Cruz, CS
Cruz, AA
de Souza, CAM
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (09) : 1814 - 1819
[2] Mild hyperkalaemia common with ACE inhibitors
[J]. Reactions Weekly, 1998, 688 (1) : 5 - 5
[3] Risk factors for spironolactone-associated hyperkalaemia
[J]. Reactions Weekly, 2003, 962 (1) : 3 - 3
[4] Cotrimoxazole ups hyperkalaemia risk in elderly receiving spironolactone
[J]. Reactions Weekly, 2011, 1370 (1) : 1 - 1
[5] Hyperkalaemia with amiloride, spironolactone
[J]. Reactions Weekly, 2021, 1873 (1) : 4 - 4
[6] Hyperkalemia induced by the association spironolactone and ACE inhibitors
Gabard, S.
Auriche, P.
Lain-Cessac, P.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 21 - 21
[7] ACE inhibitors/furosemide/spironolactone interactionHyperkalaemia: case report
[J]. Reactions Weekly, 2011, 1364 (1) : 5 - 5
[8] SAFETY OF ACE INHIBITORS AND SPIRONOLACTONE IN PAEDIATRIC HEART DISEASE
Abumehdi, M. A.
Hui, C.
Smith, N.
Liston, E.
Hunter, L.
[J]. HEART, 2018, 104 : A3 - A3
[9] ACE inhibitors/antihypertensives interactionHypotension, renal impairment and hyperkalaemia: case report
[J]. Reactions Weekly, 2012, 1390 (1) : 5 - 5
[10] Spironolactone in dialysis patients: not associated with hyperkalaemia?
[J]. Reactions Weekly, 2003, 980 (1) : 3 - 3

← 1 2 3 4 5 →